Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach
Authors
Keywords
DPP-4, GLP-1, Cardiovascular disease
Journal
ACTA DIABETOLOGICA
Volume 50, Issue 6, Pages 827-835
Publisher
Springer Nature
Online
2013-07-03
DOI
10.1007/s00592-013-0496-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
- (2013) Nasib Ervinna et al. ENDOCRINOLOGY
- Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
- (2013) Vasim Farooq et al. LANCET
- Restoring stem cell mobilization to promote vascular repair in diabetes
- (2013) Mattia Albiero et al. VASCULAR PHARMACOLOGY
- Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy
- (2012) Gian Paolo Fadini et al. BASIC RESEARCH IN CARDIOLOGY
- Phosphodiesterase Type 3A Regulates Basal Myocardial Contractility Through Interacting With Sarcoplasmic Reticulum Calcium ATPase Type 2a Signaling Complexes in Mouse Heart
- (2012) Sanja Beca et al. CIRCULATION RESEARCH
- Incretin-based therapies and cardiovascular risk
- (2012) Edoardo Mannucci et al. CURRENT MEDICAL RESEARCH AND OPINION
- Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
- (2012) T. M. Tan et al. DIABETES
- GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
- (2012) Dhanwantee Mundil et al. Diabetes & Vascular Disease Research
- Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans
- (2012) G. P. Fadini et al. DIABETES CARE
- Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
- (2012) B. Eliasson et al. DIABETOLOGIA
- Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism
- (2012) Limei Liu et al. HYPERTENSION
- Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats
- (2012) R. Preston Mason et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Sitagliptin Exerts an Antinflammatory Action
- (2012) Antoine Makdissi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
- (2012) Noriko Satoh-Asahara et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Compelling Evidence for Coronary-Bypass Surgery in Patients with Diabetes
- (2012) Mark A. Hlatky NEW ENGLAND JOURNAL OF MEDICINE
- The metabolic syndrome influences the response to incretin-based therapies
- (2011) Gian Paolo Fadini et al. ACTA DIABETOLOGICA
- Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells
- (2011) Li Ding et al. ACTA PHARMACOLOGICA SINICA
- Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries
- (2011) Veerle Matheeussen et al. BIOLOGICAL CHEMISTRY
- Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
- (2011) Meimei Yin et al. Cardiovascular Diabetology
- Renin-Angiotensin-Aldosterone Genotype Influences Ventricular Remodeling in Infants With Single Ventricle
- (2011) Seema Mital et al. CIRCULATION
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Device-Based Antihypertensive Therapy
- (2011) Henry Krum et al. CIRCULATION
- Intramyocardial BNP Gene Delivery Improves Cardiac Function Through Distinct Context-Dependent Mechanisms
- (2011) Anne-Mari Moilanen et al. Circulation-Heart Failure
- Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states
- (2011) Sarah Farr et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
- (2011) A. J. Tremblay et al. DIABETES OBESITY & METABOLISM
- Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
- (2011) M. Nagashima et al. DIABETOLOGIA
- Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure
- (2011) Nelson Gomez et al. EUROPEAN JOURNAL OF HEART FAILURE
- DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
- (2011) Nga N Ta et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Exenatide Exerts a Potent Antiinflammatory Effect
- (2011) Ajay Chaudhuri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of DPP-4 inhibition on cardiac metabolism and function in mice
- (2011) M. Lenski et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency
- (2011) Weike Bao et al. PLoS One
- Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
- (2011) Hans D. Theiss et al. Stem Cell Research
- Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes
- (2011) Susumu Ogawa et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
- (2011) Gian Paolo Fadini et al. VASCULAR PHARMACOLOGY
- Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
- (2010) Laura Pala et al. ACTA DIABETOLOGICA
- The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
- (2010) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats
- (2010) Barbara Huisamen et al. CARDIOVASCULAR DRUGS AND THERAPY
- The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus
- (2010) Naoto Katakami et al. CIRCULATION
- Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator-Activated Receptor Coactivator 1
- (2010) Z. Zheng et al. DIABETES
- Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
- (2010) M. Sauve et al. DIABETES
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
- (2010) André J. Scheen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Sitagliptin reduces albuminuria in patients with type 2 diabetes [Rapid Communication]
- (2010) Sachiko Hattori ENDOCRINE JOURNAL
- Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
- (2010) Kiwon Ban et al. ENDOCRINOLOGY
- Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) — Rationale, design and first interim analysis
- (2010) Hans D. Theiss et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats
- (2010) Bruna PM Pacheco et al. JOURNAL OF HYPERTENSION
- Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
- (2010) Liliana Ferreira et al. MEDIATORS OF INFLAMMATION
- Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
- (2009) Marc-Michael Zaruba et al. Cell Stem Cell
- The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters
- (2009) Lasse Bremholm et al. REGULATORY PEPTIDES
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension
- (2008) Goutam C. Mistry et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling
- (2008) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
- (2008) Denis Roy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema
- (2007) James Brian Byrd et al. HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search